Abstract
This study sought to compare the antimicrobial susceptibility rates between acute uncomplicated cystitis patients with failed initial antimicrobial treatment, who were considered unresolved cases, and newly presenting acute uncomplicated cystitis patients without recent antimicrobial use within 3 months and to determine whether different treatment strategies should be applied according to recent antimicrobial exposure (RAE). Female acute uncomplicated cystitis patients with Escherichia coli growth, who visited our hospital's urology department from 2010 to 2014, were divided according to RAE. The antimicrobial susceptibility of E. coli was compared between the group with RAE and the group with no antimicrobial exposure (NAE) within 3 months. The total number of acute uncomplicated cystitis patients with E. coli growth was 259: 40 patients comprised the RAE group and 219 patients formed the NAE group. The mean age was significantly older and previous recurrent cystitis history was higher in the RAE group (p < 0.05). Furthermore, the antimicrobial susceptibility of E. coli to amoxicillin-clavulanic acid, cefotaxime, cefoxitin, ciprofloxacin, and trimethoprim-sulfamethoxazole was significantly lower in the RAE group, with suscepti...Continue Reading
References
Sep 9, 2000·Archives of Internal Medicine·E Lifshitz, L Kramer
Jul 13, 2002·The American Journal of Medicine·Betsy Foxman
Oct 5, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Joong-Sik EomHee-Jin Cheong
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L Paterson
Aug 11, 2004·Mayo Clinic Proceedings·Loren G Miller, Angela W Tang
Sep 15, 2004·International Journal of Antimicrobial Agents·Seung-Ju LeeYoung Nam Woo
Dec 22, 2007·International Journal of Antimicrobial Agents·Min Eui KimYong-Hyun Cho
Jun 1, 1994·International Journal of Antimicrobial Agents·G K Harding, A R Ronald
Sep 24, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David A TalanUNKNOWN EMERGEncy ID NET Study Group
Oct 1, 2008·The American Journal of Medicine·Luke JohnsonConnie Savor Price
Sep 16, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P CassierP Chavanet
Dec 9, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Seung-Ju LeeYong-Hyun Cho
Feb 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kalpana GuptaUNKNOWN European Society for Microbiology and Infectious Diseases
Dec 14, 2011·The Journal of Urology·Alan J Wein
Jan 13, 2012·The Journal of Urology·Alan J Wein
Aug 21, 2013·Antimicrobial Agents and Chemotherapy·Dong Sup LeeSeung-Ju Lee
Citations
Aug 5, 2020·Antimicrobial Agents and Chemotherapy·Ann E StapletonMonique Twynholm
Aug 18, 2018·Therapeutic Advances in Urology·Ekaterina Kulchavenya
Jun 21, 2019·Current Pharmaceutical Design·Lernik Issakhanian, Payam Behzadi
Oct 26, 2018·BioMed Research International·Dong Sup LeeHyun-Sop Choe
Apr 11, 2018·Infection & chemotherapy·Cheol In KangSeong Heon Wie
Dec 7, 2019·Journal of Clinical Medicine·Suman KapurShashwat Sharad
Dec 20, 2020·Antibiotics·Ji Young ParkJin Han Kang
Jul 4, 2021·Infection & chemotherapy·Young Kyun ChoiYu Bin Seo
Jun 15, 2021·Infectious Diseases and Therapy·Xue-Er PohI-Min Chiu
Jun 16, 2021·Annals of Rehabilitation Medicine·EunYoung KimBum-Suk Lee